US 8709417
Combination immunotherapy for the treatment of cancer
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 8709417 (Combination immunotherapy for the treatment of cancer) held by BOARD OF REGENTS expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BOARD OF REGENTS
- Grant date
- Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K38/1709, A61K39/3955